BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual ...
Video: MRI in MS: The Re-baseline Effect —Because disease-modifying therapies take time to reach full effect, Robert Bermel, MD, of Cleveland Clinic, recommends repeating MRI scans after 6 months when ...
Baseline tariffs take effect as Trump doubles down President Trump doubling down overnight, arguing these tariffs will grow US manufacturing and supercharge the American economy even as stocks plunge ...
Phase 3 trial results for rolapitant, a novel NK-1 receptor antagonist, in the prevention of chemotherapy-induced nausea and vomiting (CINV) in subjects receiving highly emetogenic chemotherapy (HEC).
The 10% “baseline” tariff will go into effect at 12:01 a.m. on April 5, senior administration officials told reporters, and higher reciprocal tariffs will go into effect at 12:01 on April 9.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results